Dissecting the role of protein phosphorylation: a chemical biology toolbox

T Bilbrough, E Piemontese, O Seitz - Chemical Society Reviews, 2022 - pubs.rsc.org
Protein phosphorylation is a crucial regulator of protein and cellular function, yet, despite
identifying an enormous number of phosphorylation sites, the role of most is still unclear …

The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches

AC Joerger, AR Fersht - Annual review of biochemistry, 2016 - annualreviews.org
Inactivation of the transcription factor p53, through either direct mutation or aberrations in
one of its many regulatory pathways, is a hallmark of virtually every tumor. In recent years …

Gain of function of mutant p53 by coaggregation with multiple tumor suppressors

J Xu, J Reumers, JR Couceiro, F De Smet… - Nature chemical …, 2011 - nature.com
Many p53 missense mutations possess dominant-negative activity and oncogenic gain of
function. We report that for structurally destabilized p53 mutants, these effects result from …

The tumor suppressor p53: from structures to drug discovery

AC Joerger, AR Fersht - Cold Spring Harbor …, 2010 - cshperspectives.cshlp.org
Even 30 years after its discovery, the tumor suppressor protein p53 is still somewhat of an
enigma. p53's intimate and multifaceted role in the cell cycle is mirrored in its equally …

Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases

VN Uversky, V Davé, LM Iakoucheva… - Chemical …, 2014 - ACS Publications
Pathological Unfoldomics of Uncontrolled Chaos: Intrinsically Disordered Proteins and Human
Diseases | Chemical Reviews ACS ACS Publications C&EN CAS Find my institution Log In …

Translating p53 into the clinic

CF Cheok, CS Verma, J Baselga… - Nature reviews Clinical …, 2011 - nature.com
Mutations in the TP53 gene are a feature of 50% of all reported cancer cases. In the other
50% of cases, the TP53 gene itself is not mutated but the p53 pathway is often partially …

Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer

APDA Bom, LP Rangel, DCF Costa… - Journal of Biological …, 2012 - ASBMB
Over 50% of all human cancers lose p53 function. To evaluate the role of aggregation in
cancer, we asked whether wild-type (WT) p53 and the hot-spot mutant R248Q could …

p63 and p73, the ancestors of p53

V Dötsch, F Bernassola… - Cold Spring …, 2010 - cshperspectives.cshlp.org
p73 and p63 are two homologs of the tumor suppressive transcription factor p53. Given the
high degree of structural similarity shared by the p53 family members, p73 and p63 can bind …

p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53

G Melino - Cell Death & Differentiation, 2011 - nature.com
Abstract p53 mutations, occurring in two-thirds of all human cancers, confer a gain of
function phenotype, including the ability to form metastasis, the determining feature in the …

Structural diversity of p63 and p73 isoforms

C Osterburg, V Dötsch - Cell death & differentiation, 2022 - nature.com
The p53 protein family is the most studied protein family of all. Sequence analysis and
structure determination have revealed a high similarity of crucial domains between p53, p63 …